These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36039920)
1. Sense of vitality is associated with cardiovascular events in type 2 diabetes independently of traditional risk factors and arterial stiffness. Vergara M; Östgren CJ; Nyström FH; Israelsson H Diabet Med; 2023 Feb; 40(2):e14938. PubMed ID: 36039920 [TBL] [Abstract][Full Text] [Related]
2. Toe brachial index predicts major acute cardiovascular events in patients with type 2 diabetes independently of arterial stiffness. Chisalita SI; Wijkman M; Davidson LT; Spångeus A; Nyström F; Östgren CJ Diabetes Res Clin Pract; 2020 Mar; 161():108040. PubMed ID: 32006647 [TBL] [Abstract][Full Text] [Related]
3. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes. Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150 [TBL] [Abstract][Full Text] [Related]
5. Aortic pulse wave velocity predicts incident cardiovascular events in patients with type 2 diabetes treated in primary care. Wijkman M; Länne T; Östgren CJ; Nystrom FH J Diabetes Complications; 2016; 30(7):1223-8. PubMed ID: 27400814 [TBL] [Abstract][Full Text] [Related]
6. Circulating TNFrII levels predict incidence of ischemic heart disease and total mortality, independently of intima media thickness and pulse wave velocity in male with type 2 diabetes. Johansson MA; Vavruch C; Östgren CJ; Nystrom FH Heart Vessels; 2021 Oct; 36(10):1591-1596. PubMed ID: 33871700 [TBL] [Abstract][Full Text] [Related]
7. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study. Kristensen FPB; Christensen DH; Mortensen MB; Maeng M; Kahlert J; Sørensen HT; Thomsen RW Cardiovasc Diabetol; 2023 Jul; 22(1):187. PubMed ID: 37495999 [TBL] [Abstract][Full Text] [Related]
8. Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial. Verma S; Bain SC; Buse JB; Idorn T; Rasmussen S; Ørsted DD; Nauck MA JAMA Cardiol; 2019 Dec; 4(12):1214-1220. PubMed ID: 31721979 [TBL] [Abstract][Full Text] [Related]
9. Severity of Cardiovascular Autonomic Neuropathy Is a Predictor Associated With Major Adverse Cardiovascular Events in Adults With Type 2 Diabetes Mellitus: A 6-Year Follow-up Study. Lai YR; Huang CC; Chang HW; Chiu WC; Tsai NW; Cheng BC; Chen JF; Lu CH Can J Diabetes; 2021 Mar; 45(2):155-161. PubMed ID: 33046397 [TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels are independently related to the incidence of ischemic heart disease in a prospective study of patients with type 2 diabetes. Vavruch C; Länne T; Fredrikson M; Lindström T; Östgren CJ; Nystrom FH Cardiovasc Diabetol; 2015 May; 14():62. PubMed ID: 25994184 [TBL] [Abstract][Full Text] [Related]
11. Diffuse idiopathic skeletal hyperostosis is associated with incident stroke in patients with increased cardiovascular risk. Harlianto NI; Oosterhof N; Foppen W; Hol ME; Wittenberg R; van der Veen PH; van Ginneken B; Mohamed Hoesein FAA; Verlaan JJ; de Jong PA; Westerink J; Rheumatology (Oxford); 2022 Jul; 61(7):2867-2874. PubMed ID: 34791065 [TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease. Sprenger L; Mader A; Larcher B; Mächler M; Vonbank A; Zanolin-Purin D; Leiherer A; Muendlein A; Drexel H; Saely CH BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34782334 [TBL] [Abstract][Full Text] [Related]
13. ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients. Gellen B; Thorin-Trescases N; Sosner P; Gand E; Saulnier PJ; Ragot S; Fraty M; Laugier S; Ducrocq G; Montaigne D; Llaty P; Rigalleau V; Zaoui P; Halimi JM; Roussel R; Thorin E; Hadjadj S Diabetologia; 2016 Nov; 59(11):2321-2330. PubMed ID: 27491833 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes. Swoboda PP; Erhayiem B; Kan R; McDiarmid AK; Garg P; Musa TA; Dobson LE; Witte KK; Kearney MT; Barth JH; Ajjan R; Greenwood JP; Plein S Cardiovasc Diabetol; 2018 Mar; 17(1):35. PubMed ID: 29506523 [TBL] [Abstract][Full Text] [Related]
15. Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction. Furtado RHM; Bonaca MP; Raz I; Zelniker TA; Mosenzon O; Cahn A; Kuder J; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Ruff CT; Nicolau JC; Gause-Nilsson IAM; Fredriksson M; Langkilde AM; Sabatine MS; Wiviott SD Circulation; 2019 May; 139(22):2516-2527. PubMed ID: 30882239 [TBL] [Abstract][Full Text] [Related]
16. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial. Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP; Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763 [TBL] [Abstract][Full Text] [Related]
17. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus. Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495 [TBL] [Abstract][Full Text] [Related]
18. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Larsson SC; Wallin A; Håkansson N; Stackelberg O; Bäck M; Wolk A Int J Cardiol; 2018 Jul; 262():66-70. PubMed ID: 29605469 [TBL] [Abstract][Full Text] [Related]
19. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus. Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896 [TBL] [Abstract][Full Text] [Related]
20. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study. Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W; J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]